BioMed Invest
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Series A
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia, Romania
Industries Focus
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Regenerative Medicine
- Neurology
- Cardiology
- Immuno-Oncology
- Healthcare IT
- Orthopedics
- Cell Therapy
- Gene Therapy
- Medical Imaging
- Medical Robotics
Investment Size:
1,000,000 to 10,000,000 USD
Investor Details Founded: 2003
BioMed Invest is a prominent Swiss venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is dedicated to supporting innovative companies in biotechnology, medical devices, diagnostics, and digital health, aiming to enhance healthcare through technological advancements. BioMed Invest provides strategic capital and expertise to entrepreneurs and growing companies, fostering the development of groundbreaking medical solutions.
The firm's investment strategy emphasizes a hands-on approach, often acting as lead or co-lead investor in funding rounds. BioMed Invest primarily targets companies in the pre-seed, seed, and Series A stages, offering financial support ranging from $1 million to $10 million. Geographically, the firm concentrates its investments in Switzerland, Germany, Austria, and select other European countries, as well as the United States. This regional focus allows BioMed Invest to leverage its extensive network and industry knowledge to identify and nurture high-potential startups.
With a strong track record of successful investments, BioMed Invest has contributed to the growth of numerous companies that have achieved significant milestones, including acquisitions by leading biopharmaceutical firms and successful public offerings. The firm's commitment to innovation and excellence has established it as a key player in the European venture capital landscape, dedicated to advancing healthcare through strategic investments in promising life sciences ventures.
Requirements
- Innovative life sciences companies in early stages
- Strong management teams
- Potential for significant impact in healthcare
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- GlycArt Biotechnology AG
- ESBATech AG
- Okairos AG
- SuppreMol GmbH
- Symetis SA
- Arpida AG
- Curetis AG
- Santhera Pharmaceuticals
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$39.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of BioMed Invest?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim